Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by MustangSalleyon Jun 09, 2021 1:06pm
166 Views
Post# 33355712

RE:RE:Received my proxy voting packages

RE:RE:Received my proxy voting packages

cowjazz wrote:
Interesting progression.

12 months ago the SP was $0.25. As it hovers today around $1.50, there's a movement afoot to overthrow the BOD and possibly deny compensation to future directors.

There are even a few arm-chair "clinical" experts who keep shouting from the peanut gallery that Dr. Witkowski should be doing this or should be doing that....doesn't he understand the need for speed? What's the matter with that guy??? 

There's a hue and cry that any further data is now inconsequential (much like heads in the French Revolution)...it's all about signing a deal. 

Golly, what could go wrong? "Meet the new boss, same as...."

I'm outta here for the summer...GLTA and don't take any wooden nickels.

Be advised: Due to limited wi-fi, I'm unable to respond to pending or future insults until early September.










Whats your problem Cowjazz? You are entitled to vote as you wish . You sold your shares from 30 cents at above $2 good for you. Now you have bought higher and now are towing the company line . What about all those investors at least 20 million shares that are under water below $2 share ? These shareholders have a right to vote . 

We have heard nothing of management why the rush for bought deal . No update or progress on clinical side ( except Witowski)  for most of the year .

Nobody is asking to get rid of the entire board . Just one person in particular . This is a public traded company after all.

Why are you so concerned anyways ?  Want more dilution via compensation package ? More of the same directionless management ?  Maybe you are going to Tolekis 's or Ray Matthews summer cabin ?  


Put me in ignore Cowjazz but you constantly are biased . You think the compensation is fair ?


Ms Sally 
 

<< Previous
Bullboard Posts
Next >>